PubMed Journals Articles About "Gut Microbiota And Multiple Sclerosis" RSS

03:27 EDT 22nd March 2019 | BioPortfolio

Gut Microbiota And Multiple Sclerosis PubMed articles on BioPortfolio. Our PubMed references draw on over 21 million records from the medical literature. Here you can see the latest Gut Microbiota And Multiple Sclerosis articles that have been published worldwide.

More Information about "Gut Microbiota And Multiple Sclerosis" on BioPortfolio

We have published hundreds of Gut Microbiota And Multiple Sclerosis news stories on BioPortfolio along with dozens of Gut Microbiota And Multiple Sclerosis Clinical Trials and PubMed Articles about Gut Microbiota And Multiple Sclerosis for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Gut Microbiota And Multiple Sclerosis Companies in our database. You can also find out about relevant Gut Microbiota And Multiple Sclerosis Drugs and Medications on this site too.

Showing "Microbiota Multiple Sclerosis" PubMed Articles 1–25 of 11,000+

Biotinidase deficiency should be considered in individuals thought to have multiple sclerosis and related disorders.

Multiple sclerosis is a disorder of the central and peripheral nervous system of young and old adults that is characterized by muscle, coordination and vision abnormalities. Multiple sclerosis is likely due to numerous causes.

Necessity of technicians for computerized neuropsychological assessment devices in multiple sclerosis.

Determine the influence of technician supervision on computer-administered cognitive tests in multiple sclerosis (MS).

Over three decades study populations in progressive multiple sclerosis have become older and more disabled, but have lower on-trial progression rates: A systematic review and meta-analysis of 43 randomised placebo-controlled trials.

Progression is the major driver of disability and cost in multiple sclerosis (MS). However, the search for treatments in progressive multiple sclerosis (PMS) has not mirrored the success in relapsing MS.

Gut microbiota, cannabinoid system and neuroimmune interactions: New perspectives in multiple sclerosis.

The gut microbiota plays a fundamental role on the education and function of the host immune system. Immunological dysregulation is the cause of numerous human disorders such as autoimmune diseases and metabolic disorders frequently associated with inflammatory processes therefore is critical to explore novel mechanisms involved in maintaining the immune system homeostasis. The cannabinoid system and related bioactive lipids participate in multiple central and peripheral physiological processes that affect ...

Symptomatology and symptomatic treatment in multiple sclerosis: Results from a nationwide MS registry.

Multiple sclerosis (MS) is a neuroinflammatory and neurodegenerative disease. Over time, symptoms accumulate leading to increased disability of patients.

Acid sphingomyelinase: No potential as a biomarker for multiple sclerosis.

Multiple sclerosis (MS) lacks reliable biomarkers that reflect disease activity. Recent evidence suggests that an altered sphingolipid metabolism is associated with MS pathogenesis.

Mining healthcare data for markers of the multiple sclerosis prodrome.

Previous studies suggest the existence of a prodromal period in multiple sclerosis, but little is known about the phenotypic characteristics. This study aims to characterize the multiple sclerosis (MS) prodrome using data mining analytics in the healthcare setting.

Hypocomplementemic urticarial vasculitis and multiple Sclerosis: A rare association or an atypical presentation?

Multiple Sclerosis (MS) has been associated with several immune-mediated diseases but the mechanisms that explain such associations, as well as their implications in clinical practice and treatment are rarely discussed.

Gut microbiota in neurodegenerative disorders.

Gut dysbiosis, a primary factor behind various gastrointestinal disorders may also augment lipopolysaccharides, pro-inflammatory cytokines, T helper cells and monocytes causing increased intestinal and BBB permeability via microbiota-gut-brain axis. Consequentially, accumulation of misfolded proteins, axonal damage and neuronal demyelination sets in, thus facilitating the pathogenesis of neurodegenerative disorders like Parkinson's disease, Alzheimer's disease, multiple sclerosis and amyotrophic lateral scl...

The role of gluten in multiple sclerosis: A systematic review.

There is an increasing interest in diet as a modifying factor in multiple sclerosis (MS), and gluten has been suggested to affect MS.

Polyneuropathies and chronic inflammatory demyelinating polyradiculoneuropathy in multiple sclerosis.

Polyneuropathies co-occurring with multiple sclerosis (MS) may be underdiagnosed while causing additional disability burden.

Metabolomic profile of insulin resistance in patients with multiple sclerosis is associated to the severity of the disease.

Dysglycemia and adiposity have been related to disability in patients with multiple sclerosis. The objective of this work was to determine the prevalence and characteristics of insulin resistance in patients with multiple sclerosis using the metabolomics Quantose score.

A first investigation of tongue, lip, and jaw movements in persons with dysarthria due to multiple sclerosis.

Multiple sclerosis can affect the speech motor system and result in dysarthria.

Structural connectivity in multiple sclerosis and modeling of disconnection.

Multiple sclerosis (MS) is characterized by focal white matter damage, and when the brain is modeled as a network, lesions can be treated as disconnection events.

Impact of early diagnosis on clinical characteristics of an Italian sample of people with multiple sclerosis recruited online.

In order to anticipate the diagnosis of Multiple Sclerosis (MS), the diagnostic criteria had been reviewed several times in the last years.

Headache characteristics in multiple sclerosis.

The aims of this study were to study the prevalence and characteristics of headache in patients with multiple sclerosis and to clarify the relationship between headache and multiple sclerosis therapies.

Natural products: Potential therapeutic agents in multiple sclerosis.

Multiple sclerosis is an autoimmune neurodegenerative disease, which usually caused by inflammation, demyelination, and axonal injury. The currently available medications for multiple sclerosis do not directly promote myelin sheath repair. Therefore, many researches have attempted to achieve better therapeutic effects through promoting remyelination. Natural products not only alleviate clinical symptoms, but also have the unique advantages of protecting and repairing effects on nervous system. We here prese...

Multiple sclerosis relapse: Qualitative findings from clinician and patient interviews.

In patients with relapsing forms of multiple sclerosis (MS), relapses are often unrecognized. These missed relapses have broad implications for the conduct of clinical trials as well as for the care and prognosis of people with multiple sclerosis (MS). With the ultimate goal of developing new methods to identify relapse, the purpose of this qualitative research with patients and clinicians was to examine the definition, symptoms, and impact of relapse.

Relapse prevalence, symptoms, and health care engagement: patient insights from the Multiple Sclerosis in America 2017 survey.

Underestimation of relapse in multiple sclerosis (MS) is detrimental to the patient as well as to their relationship with their MS healthcare professional (HCP).

Olfactory function and cognition in relapsing-remitting and secondary-progressive multiple sclerosis.

Both cognition and olfaction are impaired in multiple sclerosis (MS). However, little is known about the relationship between smell identification ability and measures of cognitive function in this disease.

Multiple Sclerosis: kFLC index values related to gender.

Multiple sclerosis (MS) is a chronic multifactorial inflammatory and neurodegenerative disease of the central nervous system (CNS). The identification of biomarkers with good diagnostic and prognostic power is of great importance for monitoring and treating MS patients.

Diabetes and anxiety adversely affect cognition in multiple sclerosis.

To determine whether comorbid diabetes and hypertension are associated with cognition in multiple sclerosis (MS) after accounting for psychiatric comorbidities.

Validity of a multi-domain computerized cognitive assessment battery for patients with multiple sclerosis.

Computerized cognitive batteries may facilitate the integration of neuropsychological assessments into routine clinical care of patients with multiple sclerosis (PwMS).

Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions.

Chronic lesion activity driven by smoldering inflammation is a pathological hallmark of progressive forms of multiple sclerosis (MS).

Trait Conscientiousness predicts rate of longitudinal SDMT decline in multiple sclerosis.

Many people with multiple sclerosis (MS) exhibit cognitive decline over several years. Baseline differences may put people at greater risk for such decline.

Quick Search